IL250080B - Methods for treating patients with heterozygous familial hypercholesterolemia (hefh) - Google Patents
Methods for treating patients with heterozygous familial hypercholesterolemia (hefh)Info
- Publication number
- IL250080B IL250080B IL250080A IL25008017A IL250080B IL 250080 B IL250080 B IL 250080B IL 250080 A IL250080 A IL 250080A IL 25008017 A IL25008017 A IL 25008017A IL 250080 B IL250080 B IL 250080B
- Authority
- IL
- Israel
- Prior art keywords
- hefh
- methods
- treating patients
- familial hypercholesterolemia
- heterozygous familial
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Obesity (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462025362P | 2014-07-16 | 2014-07-16 | |
US201462043144P | 2014-08-28 | 2014-08-28 | |
US201462080717P | 2014-11-17 | 2014-11-17 | |
EP15305419 | 2015-03-23 | ||
PCT/US2015/040754 WO2016011256A1 (en) | 2014-07-16 | 2015-07-16 | METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) |
Publications (2)
Publication Number | Publication Date |
---|---|
IL250080A0 IL250080A0 (en) | 2017-03-30 |
IL250080B true IL250080B (en) | 2020-08-31 |
Family
ID=67107254
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL250080A IL250080B (en) | 2014-07-16 | 2017-01-12 | Methods for treating patients with heterozygous familial hypercholesterolemia (hefh) |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP7104108B2 (en) |
ES (1) | ES2779402T3 (en) |
IL (1) | IL250080B (en) |
PT (1) | PT3169353T (en) |
ZA (1) | ZA201700195B (en) |
-
2015
- 2015-07-16 PT PT157532276T patent/PT3169353T/en unknown
- 2015-07-16 ES ES15753227T patent/ES2779402T3/en active Active
-
2017
- 2017-01-10 ZA ZA2017/00195A patent/ZA201700195B/en unknown
- 2017-01-12 IL IL250080A patent/IL250080B/en active IP Right Grant
-
2020
- 2020-07-29 JP JP2020127851A patent/JP7104108B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
IL250080A0 (en) | 2017-03-30 |
ES2779402T3 (en) | 2020-08-17 |
JP7104108B2 (en) | 2022-07-20 |
PT3169353T (en) | 2020-03-26 |
JP2020183439A (en) | 2020-11-12 |
ZA201700195B (en) | 2019-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL283561B (en) | Methods for treating ocular diseases | |
PL3169353T3 (en) | Methods for treating patients with heterozygous familial hypercholesterolemia (hefh) | |
IL278018A (en) | Methods for treating or preventing ophthalmological conditions | |
IL249065A0 (en) | Combination therapies for the treatment of cancer | |
IL262591A (en) | Methods for treating patients with familial hypercholesterolemia | |
PL3389778T3 (en) | Device for photodynamic treatment | |
ZA201700416B (en) | Methods for treating or preventing ophthalmological conditions | |
PL3169362T3 (en) | Methods for treating high cardiovascular risk patients with hypercholesterolemia | |
PL3231444T3 (en) | New treatment | |
HK1215864A1 (en) | Cannula for catgut-embedding therapy | |
IL251790A0 (en) | Thiazolyl-containing compounds for treating proliferative diseases | |
IL259850A (en) | Gene therapy for treating familial hypercholesterolemia | |
SI3164394T1 (en) | Gls1 inhibitors for treating diseases | |
IL252904A0 (en) | Methods and agents for treating disease | |
ZA201608820B (en) | Method for treating drug resistant cancer | |
HK1210590A1 (en) | Method for the treatment of hypercholesterolemia | |
IL250080A0 (en) | Methods for treating patients with heterozygous familial hypercholesterolemia (hefh) | |
IL250083A0 (en) | Methods for treating high cardiovascular risk patients with hypercholesterolemia | |
GB201412441D0 (en) | Treatment system | |
GB201417719D0 (en) | New treatment | |
GB201409172D0 (en) | Anti tipping device for chair | |
SG10201400823PA (en) | Therapeutic methods and compositions for treating diabetes | |
GB201408384D0 (en) | New treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed | ||
KB | Patent renewed |